Macroglobulinemia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
MeshID = D008258 | | MeshID = D008258 | | ||
}} | }} | ||
{{SI}} | |||
{{Editor Help}} | |||
'''Macroglobulinemia''' is the presence of increased levels of [[macroglobulin]]s in the circulating [[blood]]. | '''Macroglobulinemia''' is the presence of increased levels of [[macroglobulin]]s in the circulating [[blood]]. | ||
A plasma cell [[dyscrasia]] resembling [[leukemia]] with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an [[immunoglobulin M]] monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 28th ed) | A plasma cell [[dyscrasia]] resembling [[leukemia]] with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an [[immunoglobulin M]] monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 28th ed) | ||
Revision as of 16:27, 9 January 2009
| Macroglobulinemia | |
| ICD-9 | 273.3 |
|---|---|
| MeSH | D008258 |
|
WikiDoc Resources for Macroglobulinemia |
|
Articles |
|---|
|
Most recent articles on Macroglobulinemia Most cited articles on Macroglobulinemia |
|
Media |
|
Powerpoint slides on Macroglobulinemia |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Macroglobulinemia |
|
Clinical Trials |
|
Ongoing Trials on Macroglobulinemia at Clinical Trials.gov Trial results on Macroglobulinemia Clinical Trials on Macroglobulinemia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Macroglobulinemia NICE Guidance on Macroglobulinemia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Macroglobulinemia Discussion groups on Macroglobulinemia Patient Handouts on Macroglobulinemia Directions to Hospitals Treating Macroglobulinemia Risk calculators and risk factors for Macroglobulinemia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Macroglobulinemia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Macroglobulinemia is the presence of increased levels of macroglobulins in the circulating blood. A plasma cell dyscrasia resembling leukemia with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an immunoglobulin M monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 28th ed)